These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7690450)

  • 21. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
    Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
    Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.
    Gnagey AL; Seidenberg M; Ellis J
    Mol Pharmacol; 1999 Dec; 56(6):1245-53. PubMed ID: 10570052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
    Lee NH; Hu J; el-Fakahany EE
    J Pharmacol Exp Ther; 1992 Jul; 262(1):312-6. PubMed ID: 1625205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-di benzo[b,e][1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes.
    Ellis J; Seidenberg M
    Biochem Pharmacol; 1999 Jan; 57(2):181-6. PubMed ID: 9890566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
    Tränkle C; Weyand O; Schröter A; Mohr K
    Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
    Huang XP; Ellis J
    Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
    Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
    Lee NH; el-Fakahany EE
    J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
    Buller S; Zlotos DP; Mohr K; Ellis J
    Mol Pharmacol; 2002 Jan; 61(1):160-8. PubMed ID: 11752217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
    Wess J; Bonner TI; Brann MR
    Mol Pharmacol; 1990 Dec; 38(6):872-7. PubMed ID: 2174507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
    Tränkle C; Mohr K
    Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    Wess J; Gdula D; Brann MR
    Mol Pharmacol; 1992 Feb; 41(2):369-74. PubMed ID: 1538713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J; Wang SZ; Forray C; el-Fakahany EE
    Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors.
    Tränkle C; Elis K; Wiese M; Mohr K
    Life Sci; 1997; 60(22):1995-2003. PubMed ID: 9180353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.